Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
Identifieur interne : 000C39 ( Istex/Curation ); précédent : 000C38; suivant : 000C40Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
Auteurs : Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-05-15.
Url:
DOI: 10.1002/mds.23021
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C39
Links to Exploration step
ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease</title><author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Lang, Anthony" sort="Lang, Anthony" uniqKey="Lang A" first="Anthony" last="Lang">Anthony Lang</name><affiliation wicri:level="1"><mods:affiliation>Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23021</idno><idno type="url">https://api-v5.istex.fr/document/F94B7C300C6BE8519E0E67511772AE7C00D019C2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C39</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C39</idno><idno type="wicri:Area/Istex/Curation">000C39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease</title><author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Lang, Anthony" sort="Lang, Anthony" uniqKey="Lang A" first="Anthony" last="Lang">Anthony Lang</name><affiliation wicri:level="1"><mods:affiliation>Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-05-15">2010-05-15</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="961">961</biblScope><biblScope unit="page" to="962">962</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">F94B7C300C6BE8519E0E67511772AE7C00D019C2</idno><idno type="DOI">10.1002/mds.23021</idno><idno type="ArticleID">MDS23021</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000C39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2
|texte= Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. |  |